smith&nephew OXINIUM Femoral Head 12/14 Taper, REF 71343204, 32 MM OD +4, Sterile; and smith&nephew, 12/14 Taper, REF... — FDA record Z-1901-2024

Reported ongoing

Status as reported in the agency record. FDA warns that enforcement status may not track the current recall lifecycle; check the current official notice.

Source date Apr 24, 2024. Retrieved Oct 1, 2026. Last updated Oct 1, 2026.

Archive changed Oct 1, 2026. USDA FSIS records are unavailable; check FSIS directly. Source coverage and dates.

What the record says

Product
smith&nephew OXINIUM Femoral Head 12/14 Taper, REF 71343204, 32 MM OD +4, Sterile; and smith&nephew, 12/14 Taper, REF 71343604, 36 MM M / +4
Reason
Packaging contained the incorrect size of femoral head from what was displayed on the label.
Classification
Class II
Recalling firm
Smith & Nephew Inc
Quantity
23 packages
Agency-reported status
Ongoing
Source record identifier
Z-1901-2024

Open the official record

What the recall classes mean. Classification is an agency assessment, not individual medical advice.

Lot and product identifiers

Label fieldDetails supplied by the agency
Lot, code or applicabilityREF 71343204 - Batch #23FM03219, Exp. June 2033; REF 71343604 - Batch 23FM04184, Exp. June 2033.

Match all identifying details in the current notice. A brand name alone is not enough.

Distribution

International distribution to the countries of Australia, Germany, Japan, Portugal, and United Kingdom.

No US distribution state could be established from this record. Check the official notice.

Dates in the source

Report date
Jun 5, 2024
Recall initiation date
Apr 24, 2024
Center classification date
May 24, 2024

FDA company pages use the listing date; enforcement records use initiation dates; CPSC uses recall date; NHTSA uses report-received date. These dates are not interchangeable.

Related records